Comments on “Prevalence, patient characteristics and outcomes of high-dose upadacitinib in inflammatory bowel disease”

Aliza Altaf, Fiza Memon, Lavish Kumar

Therapeutic Advances in Gastroenterology

Published online on July 02, 2026